Live from the NIH registry
Studies recruiting near St. Paul right now
Top 25 of 1,085 recruiting studies, sorted by proximity — each links to its official registry page
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Any Solid Oral Medication
N/A
Interventional 200 participants sought
Allina — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Dosentrx Ltd.
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Minnesota Oncology Hematology, P.A. — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
VitreoRetinal Surgery, PLLC. — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Genentech, Inc.
mHealth Estimate-based Algorithms Signaling Upcoming Recurrence of Episodes in Bipolar Disorders
Bipolar Disorder
N/A
Observational 200 participants sought
Minneapolis VA Health Care System, Minneapolis, MN — Minneapolis, Minnesota (8.1 mi)
· Sponsor: VA Office of Research and Development
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Phase 3
Interventional 904 participants sought
Metro-Minnesota Community Clinical Oncology ( Site 0144) — Saint Louis Park, Minnesota (11.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
Regions Hospital — Saint Paul, Minnesota (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Phase 1
Interventional 36 participants sought
University of Minnesota — Minneapolis, Minnesota (8.1 mi)
· Sponsor: PeproMene Bio, Inc.
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
Tibial Fractures, Pain
Phase 3
Interventional 1,000 participants sought
Hennepin Health — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Retina Consultants of Minnesota PLLC — Saint Louis Park, Minnesota (11.9 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Listening Effort in Cochlear Implant Users
Auditory Perception; Abnormal, Hearing Loss, Sensorineural
N/A
Interventional 450 participants sought
University of Minnesota — Minneapolis, Minnesota (8.1 mi)
· Sponsor: University of Minnesota
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
MNGI Digestive Health PA-Plymouth — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Takeda
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck
Phase 1
Interventional 1,006 participants sought
Allina Health Cancer Institute - United Hospital — Saint Paul, Minnesota (0.6 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 12 participants sought
Masonic Cancer Center, University of Minnesota — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Masonic Cancer Center, University of Minnesota
Type 1 Diabetes Extension Study
Type 1 Diabetes Mellitus, T1DM
N/A
Observational 111 participants sought
University of Minnesota — Minneapolis, Minnesota (8.1 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Brain Cancer, Breast Cancer
N/A
Observational 7,000 participants sought
Allina Health Cancer Institute — Minneapolis, Minnesota (8.1 mi)
· Sponsor: Adela, Inc
Epidural Stimulation After Neurologic Damage: Long-Term Outcomes
SCI - Spinal Cord Injury
N/A
Interventional 50 participants sought
Hennepin County Medical Center — Minneapolis, Minnesota (8.1 mi)
· Sponsor: University of Minnesota
A Long-Term Observational Study of Patients With Fucosidosis
Fucosidosis
N/A
Observational 57 participants sought
University of Minnesota Health — Minneapolis, Minnesota (8.1 mi)
· Sponsor: JCR Pharmaceuticals Co., Ltd.
Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia
Oral Leukoplakia
Phase 2
Interventional 36 participants sought
HealthPartners — Saint Paul, Minnesota (0.6 mi)
· Sponsor: University of Minnesota
Targeting Transdiagnostic Self-regulatory Factors and Eating Disorder Pathology Among Adults With BInge-spectrum Eating disOrders: A mHEALTH Interoceptive Exposure Intervention (the Bio-HEALTH Study)
Eating Disorders
N/A
Interventional 144 participants sought
University of Minnesota — Minneapolis, Minnesota (8.1 mi)
· Sponsor: University of Minnesota
Microelectrode Recordings From the Vagus Nerve in Awake Humans
Epilepsy
Phase 1
Interventional 60 participants sought
University of Minnesota — Minneapolis, Minnesota (8.1 mi)
· Sponsor: University of Minnesota
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 2
Interventional 630 participants sought
Research Site — Saint Louis Park, Minnesota (11.9 mi)
· Sponsor: AstraZeneca
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Systemic Lupus Erythematosus
Phase 3
Interventional 100 participants sought
Research Site — Saint Paul, Minnesota (0.6 mi)
· Sponsor: AstraZeneca
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Multiple conditions
Phase 2
Interventional 150 participants sought
Regions Hospital — Saint Paul, Minnesota (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women
Vulvo Vaginal Atrophy (VVA)
Phase 2
Interventional 90 participants sought
Nucleus Network — Saint Paul, Minnesota (0.6 mi)
· Sponsor: Azure Biotech Inc.
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 180 participants sought
Minnesota Clinical Study Center — New Brighton, Minnesota (9.4 mi)
· Sponsor: Organon and Co